Home » Topics » Regulatory

Regulatory
RSS

Chirocaine receives first regulatory approval in Sweden

Dec. 18, 1998

Orphan Medical files NDS for Busulfex Injection in Canada

Dec. 17, 1998

Eisai launches new formulation of antiarrhythmic drug in Japan

Dec. 16, 1998

FDA approves expanded indication for CytoGam

Dec. 14, 1998

Philippines is the first market for lamivudine as anti-HBV agent

Dec. 14, 1998

Schering-Plough files NDA for next-generation corticosteroid

Dec. 14, 1998

FDA approves Rebetron combination therapy for previously untreated HCV patients

Dec. 11, 1998

FDA approves Sandostatin LAR once-monthly depot formulation

Dec. 7, 1998

Canadian approval obtained for Serostim

Dec. 4, 1998

FDA approves Hycamtin as second-line treatment of small cell lung cancer

Dec. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...